← Back to catalogue

Cancer Antigen 15-3 (eCLIA)

EUDAMED

Class C (EU MDR)

Ref 0320500702Model 50T, 2×50T, 100T, 2×100TModel 2×50 T

by Shenzhen Lifotronic Technology Co., Ltd.

Identity

Trade Name
Cancer Antigen 15-3 (eCLIA) EUDAMED
Device Name
Cancer Antigen 15-3 (eCLIA) EUDAMED
Model / Reference
50T, 2×50T, 100T, 2×100T EUDAMED
0320500702 EUDAMED
2×50 T EUDAMED

Identifiers

Primary DI / UDI-DI
06975984063379 EUDAMED
Basic UDI-DI
69703416803205027JF EUDAMED
B-06975984063379 EUDAMED
EMDN Code
W0102030102 CANCER ANTIGEN 15-3 EUDAMED

Classification

Device Class
Class C EUDAMED
Class IVD General EUDAMED
Market of Registration
Germany EUDAMED

Clinical & Handling

Sterile

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Microbial Substances

No

EUDAMED

Reagent

Yes

EUDAMED

Self Testing

No

EUDAMED

Near-Patient Testing

No

EUDAMED

Professional Testing

Yes

EUDAMED

Companion Diagnostics

No

EUDAMED

Surgical Instrument

No

EUDAMED

New Device

No

EUDAMED

Cancer Antigen 15-3 (eCLIA) by Shenzhen Lifotronic Technology Co., Ltd. — Class C — IVDD, IVDR — listed in EUDAMED — regulatory data on deviCERTS

Authorization Coverage (European Union — 27 member states)

Regulatory Authorizations

European Union Active

CE/IVDD

European Union Active

CE/IVDR

Is this your device? Claim it to add documentation and request validation.

Manufacturer

EUDAMED SRN
CN-MF-000005654
Authorised Representative
Shanghai International Holding Corp. GmbH(Europe) DE-AR-000000001

Sources (2)

  • EUDAMED 24737573-4002-45f0-b899-21f355bf6f22 61 fields · synced Jul 22, 2026
  • EUDAMED 75118796-2dc3-4d82-800e-3f0459db3286 61 fields · synced May 19, 2026